Business

Boston Scientific announces upcoming investor conference schedule

Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences.

articleBoston Scientific CorporationNovember 3, 20252/company/boston-scientific-corp/news/boston-scientific-announces-upcoming-investor-130000306
Boston Scientific announces upcoming investor conference schedule

About this update from Boston Scientific Corporation

[{"type":"text","content":"MARLBOROUGH, Mass., Nov. 3, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences.","length":145,"tagName":"p"},{"type":"image","alt":"Boston Scientific Corporation (PRNewsFoto/Boston Scientific Corporation) (PRNewsFoto/Boston Scientific Corporation)","displaySize":"","headline":null,"caption":"Boston Scientific Corporation (PRNewsFoto/Boston Scientific Corporation) (PRNewsFoto/Boston Scientific Corporation)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":209,"url":"https://media.zenfs.com/en/prnewswire.com/02e6d5e710acee0e3d3509b5490e4888"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/UMeP4sdxPV_Oy_EDHVZ1lA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM2ODtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/02e6d5e710acee0e3d3509b5490e4888","width":400,"height":209}},"href":"https://mma.prnewswire.com/media/329537/Boston_Scientific_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"On November 18, 2025, Kenneth Stein, M.D., senior vice president and global chief medical officer, and Lauren Tengler, vice president, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst at Wolfe Research's 7th Annual Healthcare Conference. The session will begin at approximately 8:00 a.m. ET.","length":348,"tagName":"p"},{"type":"text","content":"On December 2, 2025, Joe Fitzgerald, executive vice president and group president, Cardiology, Janar Sathananthan, M.D., chief medical officer, Interventional Cardiology Therapies, and Lauren Tengler, vice president, Investor Relations will participate in a 40-minute question-and-answer session with the host analyst at Citi's 2025 Global Healthcare Conference. The session will begin at approximately 9:00 a.m. ET.","length":420,"tagName":"p"},{"type":"text","content":"A live webcast and replay for each event will be accessible at https://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.","length":193,"tagName":"p"},{"type":"text","content":"About Boston Scientific Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advan...

More updates from Boston Scientific Corporation

Boston Scientific CorporationInvestor Relationsinvestor conferencesLauren Tenglersenior vice presidentGlobal Healthcare ConferenceInterventional CardiologyJoe FitzgeraldKenneth SteinWolfe Research